Pure Bioscience
(OTC) PURE
Pure Bioscience Financials at a Glance
Market Cap
$9.14M
Revenue (TTM)
$2.41M
Net Income (TTM)
$2.16M
EPS (TTM)
$-0.02
P/E Ratio
-4.23
Dividend
$0.00
Beta (Volatility)
0.27 (Low)
Dividend
$0.00
Beta (Volatility)
0.27 (Low)
Price
$0.08
Volume
20,150
Open
$0.08
Price
$0.08
Volume
20,150
Open
$0.08
Previous Close
$0.08
Daily Range
$0.08 - $0.08
52-Week Range
$0.04 - $0.21
Dividend
$0.00
Beta (Volatility)
0.27 (Low)
Price
$0.08
Volume
20,150
Open
$0.08
Previous Close
$0.08
Daily Range
$0.08 - $0.08
52-Week Range
$0.04 - $0.21
PURE News
PURE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pure Bioscience
Industry
Household Products
Sector
Consumer StaplesEmployees
12
CEO
Robert F. Bartlett
Website
www.purebio.comHeadquarters
El Cajon, CA 91730, US
PURE Financials
Key Financial Metrics (TTM)
Gross Margin
541%
Operating Margin
-82%
Net Income Margin
-90%
Return on Equity
0%
Return on Capital
87%
Return on Assets
-3%
Earnings Yield
-23.64%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$9.14M
Shares Outstanding
111.89M
Volume
20.15K
Short Interest
0.00%
Avg. Volume
29.03K
Financials (TTM)
Gross Profit
$1.30B
Operating Income
$2.27M
EBITDA
$2.10M
Operating Cash Flow
$2.02B
Capital Expenditure
$0.00
Free Cash Flow
$2.02B
Cash & ST Invst.
$334.00M
Total Debt
$5.24B
Pure Bioscience Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$444.00K
+13.6%
Gross Profit
$238.00K
+4.8%
Gross Margin
53.60%
N/A
Market Cap
$9.14M
N/A
Market Cap/Employee
$831.01K
N/A
Employees
11
N/A
Net Income
$785.00K
+1.6%
EBITDA
$683.00K
+6.1%
Quarterly Fundamentals
Net Cash
$5.95M
-57.6%
Accounts Receivable
$252.00K
+40.0%
Inventory
$244.00K
+225.3%
Long Term Debt
$4.01M
+0.8%
Short Term Debt
$2.14M
N/A
Return on Assets
-2.74%
N/A
Return on Invested Capital
87.43%
N/A
Free Cash Flow
$606.00K
-11.4%
Operating Cash Flow
$606.00K
-11.4%